Stay updated on Maintenance Therapy Trial: Odetiglucan & CD40 Agonist

Sign up to get notified when there's something new on the Maintenance Therapy Trial: Odetiglucan & CD40 Agonist page.
Latest website image capture
Clouds background image

Latest updates to the Maintenance Therapy Trial: Odetiglucan & CD40 Agonist page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Updates the displayed ClinicalTrials.gov page revision/version from **v3.5.2** to **v3.5.3** without changing the underlying study information.
    Difference
    0.1%
    Check dated 2026-04-24T05:56:51.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:33:26.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added; Revision: v3.4.3 removed.
    Difference
    0.1%
    Check dated 2026-03-19T04:45:07.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T00:24:54.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. The previous Revision: v3.4.1 notice and the government funding lapse notice were removed.
    Difference
    0.4%
    Check dated 2026-02-11T12:14:26.000Z thumbnail image
  8. Check
    98 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding, warning that information may not be up to date and transactions may not be processed (with links to cc.nih.gov and opm.gov). Updated the page revision to v3.4.1, replacing v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-04T06:53:28.000Z thumbnail image

Stay in the know with updates to Maintenance Therapy Trial: Odetiglucan & CD40 Agonist

Enter your email address, and we'll notify you when there's something new on the Maintenance Therapy Trial: Odetiglucan & CD40 Agonist page.